Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man

Experimental Neurology

Volumn 185, Issue 2, 2004, Pages 232-240

  Fischer, Lindsey R ^a   Culver, Deborah G ^a   Tennant, Philip ^a   Davis, Albert A ^a   Wang, Minsheng ^a   Castellano Sanchez, Amilcar ^a   Khan, Jaffar ^a   Polak, Meraida A ^a   Glass, Jonathan D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Axonopathy; Denervation; Sclerosis

Indexed keywords

SUPEROXIDE DISMUTASE;

AGE DISTRIBUTION; AMYOTROPHIC LATERAL SCLEROSIS; ANAMNESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; AUTOPSY; CASE REPORT; CAUSE OF DEATH; CELL ACTIVATION; CELL LOSS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; MALE; MICROGLIA; MOTONEURON; MUSCLE DENERVATION; NERVE DEGENERATION; NERVE ENDING; NERVE FIBER; NEUROMUSCULAR SYNAPSE; NEUROPATHOLOGY; NEUROPATHY; NONHUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPINAL CORD; VENTRAL ROOT;

EID: 0345742771     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2003.10.004     Document Type: Article

References (34)

1. Bjornskov E.K., Norris F.H. Jr., Mower-Kuby J. Quantitative axon terminal and end-plate morphology in amyotrophic lateral sclerosis. Arch. Neurol. 41:1984;527-530.
2. Bommel H., Xie G., Rossoll W., Wiese S., Jablonka S., Boehm T., Sendtner M. Missense mutation in the tubulin-specific chaperone E (Tbce) gene in the mouse mutant progressive motor neuronopathy, a model of human motoneuron disease. J. Cell Biol. 159:2002;563-569.
3. Bradley W.G., Good P., Rasool C.G., Adelman L.S. Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Ann. Neurol. 14:1983;267-277.
4. Carter G.T., Krivickas L.S., Weydt P., Weiss M.D., Miller R.G. Drug therapy for amyotrophic lateral sclerosis: where are we now? Investig. Drugs J. 6:2003;147-153.
5. Cavanagh J.B. The significance of the "dying back" process in human and experimental neurological diseases. Int. Rev. Exp. Pathol. 3:1964;219-267.
6. Chiu A.Y., Zhai P., Dal Canto M.C., Peters T.M., Kwon Y.W., Prattis S.M., Gurney M.E. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 6:1995;349-362.
7. Cifuentes-Dias C., Nicole S., Velasco M.E., Borra-Cebrian C., Panazzo C., Frugier T., Millet G., Roblot N., Joshi V., Melki J. Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. Hum. Mol. Genet. 11:2002;1439-1447.
8. Coggeshall R.E., Lekan H.A. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J. Comp. Neurol. 364:1996;6-15.
9. Coleman M.P., Perry V.H. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci. 25:2002;532-537.
10. Deckwerth T.L., Johnson E.M. Jr. Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). Dev. Biol. 165:1994;63-72.
11. Drachman D.B., Frank K., Dykes-Hoberg M., Teismann P., Almer G., Przedborski S., Rothstein J.D. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 52:2002;771-778.
12. Ferri A., Sanes J.R., Coleman M.P., Cunningham J.M., Kato A.C. Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr. Biol. 13:2003;669-673.
13. Finn J.T., Weil M., Archer F., Siman R., Srinivasan A., Raff M.C. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J. Neurosci. 20:2000;1333-1341.
14. Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 20:2000;2534-2542.
15. Glass J.D. Pathophysiology of nerve and root disorders. McArthur J. Diseases of the Nervous System: Clinical Neuroscience and Therapeutic Principles. vol. II:2002;1075-1091 Cambridge Univ. Press, Cambridge.
16. Glass J.D., Fedor H., Wesselingh S.L., McArthur J.C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38:1995;755-762.
17. Graeber M.B., Streit W.J., Kreutzberg G.W. Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J. Neurosci. Res. 21:1988;18-24.
18. Griffin J.W., Watson D.F. Axonal transport in peripheral neuropathies. Ann. Neurol. 23:1988;3-13.
19. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., Lalli G., Witherden A.S., Hummerich H., Nicholson S., Morgan P.J., Oozageer R., Priestley J.V., Averill S., King V.R., Ball S., Peters J., Toda T., Yamamoto A., Hiraoka Y., Augustin M., Korthaus D., Wattler S., Wabnitz P., Dickneite C., Lampel S., Boehme F., Peraus G., Popp A., Rudelius M., Schlegel J., Fuchs H., Hrabe de Angelis M., Schiavo G., Shima D.T., Russ A.P., Stumm G., Martin J.E., Fisher E.M.C. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science. 300:2003;808-812.
20. Hall E.D., Oostveen J.A., Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia. 23:1998;249-256.
21. Johnston J.A., Dalton M.J., Gurney M.E., Kopito R.R. Formation of high molecular weight complexes of mutant Cu,Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 97:2000;12571-12576.
22. Kennel P.F., Finiels F., Revah F., Mallet J. Neuromuscular function impairment is not caused by motor neuron loss in FALS mice: an electromyographic study. NeuroReport. 7:1996;1427-1431.
23. LaMonte B., Wallace K.E., Holloway B.A., Shelly S.S., Ascano J., Tokito M., Van Winkle T., Howland D.S., Holzbaur E.L.F. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive deterioration. Neuron. 34:2002;715-727.
24. Martin N., Jaubert J., Gounon P., Salido E., Haase G., Szatanik M., Guenet J.-L. A missense mutation in Tbce causes progressive motor neuronopathy in mice. Nat. Genet. 32:2003;443-447.
25. Puls I., Jonnakuty C., LaMonte B., Holzbaur E.L.F., Tokito M., Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., Brown J., Robert H., Ludlow C.L., Fischbeck K.H. Mutant dynactin in motor neuron disease. Nat. Genet. 33:2003;455-456.
26. Rich M.M., Wang X., Cope T.C., Pinter M.J. Reduced neuromuscular quantal content with normal synaptic release time course and depression in canine motor neuron disease. J. Neurophysiol. 88:2002;3305-3314.
27. Rothstein J.D., Jin L., Dykes-Hoberg M., Kuncl R.W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 90:1993;6591-6595.
28. Sagot Y., Vejsada R., Kato A. Clinical and molecular aspects of motoneurone diseases: animal models, neurotrophic factors and Bcl-2 oncoprotein. Trends Pharmacol. Sci. 18:1997;330-337.
29. Sobue G., Hashizume Y., Sahashi K., Takahashi A., Mukai E., Matsuoka Y., Mukoyama M. Amyotrophic lateral sclerosis: lack of central chromatolytic response of motor neurocytons corresponding to active axonal degeneration. Arch. Neurol. 40:1983;306-309.
30. Spencer P.S., Schaumburg H.H. Central-peripheral distal axonopathy - The pathogenesis of dying-back polyneuropathies. Zimmerman H. Prog. Neuropathol. vol. 3:1976;253-295 Grune & Stratton, New York.
31. Tetzlaff W., Graeger M.B., Kreutzberg G.W. Reaction of motoneurons and their microenvironment to axotomy. Exp. Brain Res. (Supp. 13):1986;3-8.
32. West M.J., Slomianka L., Gundersen H.J.G. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231:1991;482-497.
33. Williamson T.L., Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2:1999;50-56.
34. Zhang B., Tu P., Abtahian F., Trojanowski J.Q., Lee V.M. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol. 139:1997;1307-1315.